key: cord-0993549-bzhjfchm
authors: Javanmard, Shaghayegh Haghjooy; Vaseghi, Golnaz; Nezhad, Amir Reza Manteghi; Nasirian, Maryam
title: Neutrophil-to-lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
date: 2020-08-15
journal: J Glob Antimicrob Resist
DOI: 10.1016/j.jgar.2020.07.029
sha: 6cbf20cc8749d5ba54d7be31417040bc154b4ed9
doc_id: 993549
cord_uid: bzhjfchm

nan

Even after controlling age and sex effects, WBC>10000, Lymphs>4000, NLR>6.5

increase the chance of disease severity by 4, 6, and 5 times.

• NLR>6.5 increases the chance of death about 1.8 times after adjustment for age and sex effects.

• The average value of WBC among severe patients was significantly higher than nonsevere whereas there was no significant difference between the two groups in the average value of lymphocytes In conclusion, the current study supports that NLR may be a rapid, easy, and a favored pointof-care test for patient stratification and an efficient tool for prioritization of health care system resources. 

Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

Isfahan COvid-19 REgistry (I-CORE): Design and methodology

Neutrophil-to lymphocyteratioasanindependentriskfactorformortalityinhospitalizedpatientswithCOVID-19

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China